Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: CSPC Pharmaceutical Group Limited

Capitalization 106B 13.53B 11.62B 10.5B 10.06B 18.37B 1,243B 18.95B 124B 49.54B 596B 50.79B 49.71B 2,133B P/E ratio 2025 *
19.2x
P/E ratio 2026 * 14.4x
Enterprise value 95.26B 12.18B 10.45B 9.45B 9.05B 16.53B 1,118B 17.05B 111B 44.57B 536B 45.7B 44.72B 1,920B EV / Sales 2025 *
3.06x
EV / Sales 2026 * 2.66x
Free-Float
70.45%
Yield 2025 *
3.19%
Yield 2026 * 3.88%
1 day-2.48%
1 week+0.44%
Current month-8.79%
1 month-13.84%
3 months+17.43%
6 months-10.77%
Current year+7.12%
1 week 8.73
Extreme 8.73
9.48
1 month 8.73
Extreme 8.73
10.89
Current year 8.38
Extreme 8.38
10.96
1 year 4.59
Extreme 4.59
11.63
3 years 4.27
Extreme 4.27
11.63
5 years 4.27
Extreme 4.27
12.68
10 years 3.14
Extreme 3.1406
13.93
Manager TitleAgeSince
Chief Executive Officer 46 18/12/2025
Chief Operating Officer 57 18/12/2025
Corporate Officer/Principal 45 30/06/2024
Director TitleAgeSince
Chairman 72 25/08/2011
Director/Board Member 63 30/09/2010
Director/Board Member 56 19/01/2012
Change 5d. change 1-year change 3-years change Capi.($)
-2.48%+0.44%+87.34%+15.47% 13.53B
-0.70%-0.63%+20.68%+217.87% 895B
+0.46%-1.23%+45.32%+60.75% 587B
-0.19%-2.93%+4.78%+51.63% 401B
+0.84%-5.68%+9.04%+27.14% 345B
-2.63%-3.48%+20.34%+63.50% 300B
+1.47%-1.86%+23.75%+36.98% 306B
-0.02%-2.29%+22.95%+8.73% 289B
-0.41%-0.42%+14.68%+64.76% 202B
+1.32%+0.49%+26.75%+86.87% 184B
Average -0.23%-1.76%+27.56%+63.37% 352.4B
Weighted average by Cap. -0.10%-1.90%+22.49%+91.62%

Financials

2025 *2026 *
Net sales 31.1B 3.97B 3.41B 3.09B 2.95B 5.4B 365B 5.57B 36.34B 14.55B 175B 14.92B 14.6B 627B 34.33B 4.39B 3.77B 3.41B 3.26B 5.96B 403B 6.14B 40.12B 16.06B 193B 16.47B 16.12B 692B
Net income 5.52B 705M 606M 548M 524M 958M 64.8B 988M 6.45B 2.58B 31.06B 2.65B 2.59B 111B 7.29B 932M 800M 723M 692M 1.26B 85.56B 1.3B 8.52B 3.41B 41.02B 3.5B 3.42B 147B
Net Debt -10.61B -1.36B -1.16B -1.05B -1.01B -1.84B -125B -1.9B -12.4B -4.97B -59.73B -5.09B -4.98B -214B -14.49B -1.85B -1.59B -1.44B -1.38B -2.51B -170B -2.59B -16.93B -6.78B -81.55B -6.95B -6.8B -292B
Logo CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Ltd is an investment holding company primarily engaged in the manufacture and sale of pharmaceutical products. The Company operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The Company conducts its business in the domestic and overseas markets.
Employees
19,266
Date Price Change Volume
11/03/26 9.030 $ -2.48% 75,777,550
10/03/26 9.260 $ +1.20% 77,520,280
09/03/26 9.150 $ -2.35% 123,722,200
06/03/26 9.370 $ +2.97% 66,293,770
05/03/26 9.100 $ +1.22% 62,594,410
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
9.260HKD
Average target price
11.48HKD
Spread / Average Target
+24.03%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW